BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD

BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD

Item
http://www.wikidata.org/entity/Q34660110
The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in The New Drugs EraA phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL.Hematopoietic stem cell transplantation-50 years of evolution and future perspectives.Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation.The combination effects of bendamustine with antimetabolites against childhood acute lymphoblastic leukemia cells.New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?Regulatory B10 cells display an altered homoeostasis in acute graft-versus-host disease.Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL.Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies.Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicity.Dose-finding designs for trials of molecularly targeted agents and immunotherapies.
P2860

BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD

Item
http://www.wikidata.org/entity/Q34660110
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
BFR (bendamustine, fludarabine ...... uced myelosuppression and GVHD
@ast
BFR (bendamustine, fludarabine ...... uced myelosuppression and GVHD
@en
BFR (bendamustine, fludarabine ...... uced myelosuppression and GVHD
@nl
type
label
BFR (bendamustine, fludarabine ...... uced myelosuppression and GVHD
@ast
BFR (bendamustine, fludarabine ...... uced myelosuppression and GVHD
@en
BFR (bendamustine, fludarabine ...... uced myelosuppression and GVHD
@nl
prefLabel
BFR (bendamustine, fludarabine ...... uced myelosuppression and GVHD
@ast
BFR (bendamustine, fludarabine ...... uced myelosuppression and GVHD
@en
BFR (bendamustine, fludarabine ...... uced myelosuppression and GVHD
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
BFR (bendamustine, fludarabine ...... uced myelosuppression and GVHD
@en
P2093
P2860
P304
P31
P356
10.1182/BLOOD-2014-07-587519
P407
P433
P478
P50
P577
P698
P921
P932